FIELD: medicine.
SUBSTANCE: invention can be used during visit to outpatient antenatal clinic, in dispensary registration of women with recurrent miscarriage. In dispensary registration at antenatal clinic somatic and obstetric-gynecological anamnesis is collected. Women with recurrent miscarriage are divided into groups on the basis of reproductive debut. Complex of examinations aimed at identification of missed abortion syndrome in anamnesis, signs of UDCTD in mothers, presence of placental insufficiency, presence of fetus IUGR, severe pre-eclampsia, chronic intra-uterine infection, sanitised during pregnancy. Basing on the analysis of obtained information presence or absence of threat of pre-term labour is predicted.
EFFECT: invention makes it possible to predict pre-term labour in patients with primary recurrent miscarriage at outpatient clinic stage, starting from 20 weeks of gestation and therefore prevent pre-term delivery in due time, thus reducing perinatal morbidity and mortality.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING PREMATURE BIRTH IN WOMEN WITH THREATENED EARLY MISCARRIAGE AND RECURRENT MISCARRIAGE IN HISTORY | 2021 |
|
RU2755269C1 |
METHOD FOR PREDICTION OF PRETERM DELIVERY IN WOMEN WITH THREATENING LATE MISCARRIAGE AND RECURRENT MISCARRIAGE | 2024 |
|
RU2826778C1 |
METHOD FOR PRETERM DELIVERY PREDICTION | 2016 |
|
RU2626510C1 |
METHOD FOR PREDICTING PREMATURE BIRTH WITH INTRAUTERINE INFECTION OF FETUS AND ABSENCE OF CONOTRUNCUS DEFECTS | 2018 |
|
RU2673152C1 |
SCREENING METHOD FOR THROMBOPHILIA IN PATIENTS WITH HABITUAL MISCARRIAGE | 2017 |
|
RU2652894C1 |
DIAGNOSTIC TECHNIQUE FOR UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA IN FEMALES WITH PERSONAL HISTORY OF MISCARRIAGE | 2013 |
|
RU2535071C1 |
METHOD OF PREDICTING RISK OF FORMATION OF INTRAUTERINE FETUS GROWTH RETARDATION (IFGR) AT PREGNANCY STAGE | 2011 |
|
RU2482797C1 |
METHOD OF PREDICTING RETARDATION OF INTRAUTERINE FOETUS DEVELOPMENT | 2012 |
|
RU2526178C2 |
METHOD FOR PREVENTING PREECLAMPSIA IN PATIENTS WITH AN AGGRAVATED OBSTETRIC ANAMNESIS | 2016 |
|
RU2663593C2 |
METHOD FOR EVALUATING THE EFFECTIVENESS OF TREATMENT WITH INTRAVENOUS IMMUNOGLOBULINS IN FEMALE PATIENTS WITH HABITUAL MISCARRIAGE AND CIRCULATION OF ANTI-PHOSPHOLIPID ANTIBODIES | 2021 |
|
RU2775311C1 |
Authors
Dates
2013-06-27—Published
2012-02-07—Filed